{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:17:32Z","timestamp":1720657052873},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.revmed.2024.05.010","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T08:40:23Z","timestamp":1717576823000},"page":"400-408","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bon usage des opio\u00efdes forts dans les unit\u00e9s de m\u00e9decine\u00a0: \u00e9tat des lieux des recommandations et conduite \u00e0 tenir en pratique quotidienne"],"prefix":"10.1016","volume":"45","author":[{"given":"A.","family":"Mathe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sudre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Averous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"197","key":"10.1016\/j.revmed.2024.05.010_bib0220","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3406\/pharm.1968.7745","volume":"56","author":"Julien","year":"1968","journal-title":"Rev Hist Pharm"},{"issue":"1","key":"10.1016\/j.revmed.2024.05.010_bib0225","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ejp.1291","article-title":"Prescription opioid analgesic use in France: trends and impact on morbidity-mortality","volume":"23","author":"Chenaf","year":"2019","journal-title":"Eur J Pain"},{"key":"10.1016\/j.revmed.2024.05.010_bib0230","doi-asserted-by":"crossref","first-page":"960389","DOI":"10.3389\/fpain.2023.960389","article-title":"The opioid receptor: emergence through millennia of pharmaceutical sciences","volume":"4","author":"Fairbanks","year":"2023","journal-title":"Front Pain Res (Lausanne)"},{"issue":"6","key":"10.1016\/j.revmed.2024.05.010_bib0235","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"issue":"7","key":"10.1016\/j.revmed.2024.05.010_bib0240","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2217\/14622416.9.7.905","article-title":"Pharmacogenetics of analgesics: toward the individualization of prescription","volume":"9","author":"Rollason","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.revmed.2024.05.010_bib0245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3166\/dea-2020-0113","article-title":"Traitements pharmacologiques et non pharmacologiques de la douleur neuropathique\u00a0: une synth\u00e8se des recommandations fran\u00e7aises","volume":"33","author":"Moisset","year":"2020","journal-title":"Douleur Analg"},{"key":"10.1016\/j.revmed.2024.05.010_bib0250","unstructured":"Bertin C, Chappuy M, Dupouy J, Michenot N, Verdier S, Trouvin AM. Bon usage des m\u00e9dicaments opio\u00efdes\u00a0: antalgie, pr\u00e9vention et prise en charge du trouble de l\u2019usage et des surdoses. Recommandation du 10\u00a0mars 2022. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2022-03\/reco_opioides.pdf."},{"issue":"4","key":"10.1016\/j.revmed.2024.05.010_bib0255","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.lpm.2016.02.014","article-title":"Utilisation des opio\u00efdes forts dans la douleur chronique non canc\u00e9reuse chez l\u2019adulte. Recommandations fran\u00e7aises de bonne pratique clinique par consensus formalis\u00e9 (SFETD)","volume":"45","author":"Moisset","year":"2016","journal-title":"Presse Med"},{"issue":"1","key":"10.1016\/j.revmed.2024.05.010_bib0260","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1164\/ajrccm.159.1.ats898","article-title":"Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society","volume":"159","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.revmed.2024.05.010_bib0265","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/thoraxjnl-2016-209868","article-title":"One evidence base; three stories: do opioids relieve chronic breathlessness?","volume":"73","author":"Ekstr\u00f6m","year":"2018","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.revmed.2024.05.010_bib0270","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1378\/chest.12-1541","article-title":"Effect of increased blood levels of \u03b2-endorphin on perception of breathlessness","volume":"143","author":"Mahler","year":"2013","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.revmed.2024.05.010_bib0275","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(02)00713-1","article-title":"Clinical management of dyspnoea","volume":"3","author":"Thomas","year":"2002","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.revmed.2024.05.010_bib0280","doi-asserted-by":"crossref","first-page":"e001038","DOI":"10.1136\/esmoopen-2020-001038","article-title":"Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines\u2020","volume":"5","author":"Hui","year":"2020","journal-title":"ESMO Open"},{"issue":"11","key":"10.1016\/j.revmed.2024.05.010_bib0285","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thorax.57.11.939","article-title":"A systematic review of the use of opioids in the management of dyspnoea","volume":"57","author":"Jennings","year":"2002","journal-title":"Thorax"},{"issue":"36","key":"10.1016\/j.revmed.2024.05.010_bib0290","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021\u00a0ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.revmed.2024.05.010_bib0295","unstructured":"ANSM.sante.fr [page d\u2019accueil sur Internet]. Disponible en ligne \u00e0 l\u2019adresse\u00a0: https:\/\/ansm.sante.fr\/actualites\/risque-dallergie-grave-aux-curares-en-cas-dutilisation-des-sirops-contre-la-toux-contenant-de-la-pholcodine (acc\u00e8s 02\u00a0mai 2024)."},{"issue":"12","key":"10.1016\/j.revmed.2024.05.010_bib0300","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.mpmed.2022.09.008","article-title":"Symptom control in palliative care","volume":"50","author":"Gleeson","year":"2022","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.revmed.2024.05.010_bib0305","first-page":"171","article-title":"Constipation et traitements par les opio\u00efdes. Physiopathologie et prise en charge","volume":"10","author":"Ducrott\u00e9","year":"2009","journal-title":"Douleurs"},{"issue":"1","key":"10.1016\/j.revmed.2024.05.010_bib0310","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2050640618818305","article-title":"Pathophysiology and management of opioid-induced constipation: European expert consensus statement","volume":"7","author":"Farmer","year":"2019","journal-title":"United Eur Gastroenterol J"},{"issue":"6","key":"10.1016\/j.revmed.2024.05.010_bib0315","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.revmed.2024.05.010_bib0320","first-page":"147","article-title":"Prise en charge de la constipation induite par les opio\u00efdes\u00a0: regards crois\u00e9s d\u2019un gastro-ent\u00e9rologue et d\u2019un m\u00e9decin de la douleur","volume":"21","author":"Gourcerol","year":"2020","journal-title":"Douleurs"},{"issue":"1","key":"10.1016\/j.revmed.2024.05.010_bib0325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2050640618818305","article-title":"Pathophysiology and management of opioid-induced constipation: European expert consensus statement","volume":"7","author":"Farmer","year":"2019","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"10.1016\/j.revmed.2024.05.010_bib0330","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.gastro.2018.07.016","article-title":"American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation","volume":"156","author":"Crockett","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.revmed.2024.05.010_bib0335","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"issue":"37","key":"10.1016\/j.revmed.2024.05.010_bib0340","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.2174\/138161212803582540","article-title":"Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitation","volume":"18","author":"Coluzzi","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"11","key":"10.1016\/j.revmed.2024.05.010_bib0345","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.ejca.2011.04.014","article-title":"Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids","volume":"47","author":"Laugsand","year":"2011","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.revmed.2024.05.010_bib0350","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1526-4637.2009.00583.x","article-title":"Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options","volume":"10","author":"Porreca","year":"2009","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.revmed.2024.05.010_bib0355","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/pm\/pnac113","article-title":"Pain, opioid analgesics, and cognition: a conceptual framework in older adults","volume":"24","author":"Warner","year":"2022","journal-title":"Pain Med"},{"issue":"5","key":"10.1016\/j.revmed.2024.05.010_bib0360","first-page":"226","article-title":"L\u2019hyperalg\u00e9sie induite par les opio\u00efdes","volume":"14","author":"Calvino","year":"2013","journal-title":"Douleurs"},{"issue":"3","key":"10.1016\/j.revmed.2024.05.010_bib0365","doi-asserted-by":"crossref","first-page":"679","DOI":"10.36076\/ppj.2009\/12\/679","article-title":"Opioid induced hyperalgesia: clinical implications for the pain practitioner","volume":"12","author":"Silverman","year":"2009","journal-title":"Pain Physician"},{"key":"10.1016\/j.revmed.2024.05.010_bib0370","unstructured":"Frasca M, Pechard M, Treillet E. Antalgie des douleurs rebelles et pratiques s\u00e9datives chez l\u2019adulte chez l\u2019adulte\u00a0: prise en charge m\u00e9dicamenteuse en situations palliatives jusqu\u2019en fin de vie. Recommandations de bonnes pratiques de janvier 2020. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2020-02\/reco_fin_vie_med.pdf."},{"issue":"1","key":"10.1016\/j.revmed.2024.05.010_bib0375","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13341-010-0019-9","article-title":"Recommandations formalis\u00e9es d\u2019experts 2010\u00a0: s\u00e9dation et analg\u00e9sie en structure d\u2019urgence (r\u00e9actualisation de la conf\u00e9rence d\u2019experts de la SFAR de 1999)","volume":"1","author":"Vivien","year":"2011","journal-title":"Ann Fr Med Urgence"},{"issue":"5","key":"10.1016\/j.revmed.2024.05.010_bib0380","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/bja\/89.5.697","article-title":"Is morphine-induced sedation synonymous with analgesia during intravenous morphine titration?","volume":"89","author":"Paqueron","year":"2002","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.revmed.2024.05.010_bib0385","unstructured":"Haute Autorit\u00e9 de sant\u00e9. Les m\u00e9dicaments des acc\u00e8s douloureux paroxystiques du cancer. Bon usage des m\u00e9dicaments de d\u00e9cembre 2017. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2014-07\/fbum_adp_maj_juillet2014.pdf."},{"issue":"5","key":"10.1016\/j.revmed.2024.05.010_bib0390","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0269216310384902","article-title":"European Palliative Care Research Collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review","volume":"25","author":"Dale","year":"2011","journal-title":"Palliat Med"},{"issue":"3","key":"10.1016\/j.revmed.2024.05.010_bib0395","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jpainsymman.2009.06.002","article-title":"Establishing \u201cbest practices\u201d for opioid rotation: conclusions of an expert panel","volume":"38","author":"Fine","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.revmed.2024.05.010_bib0400","unstructured":"SFAP.org [page d\u2019accueil sur Internet]. Disponible en ligne \u00e0 l\u2019adresse\u00a0: http:\/\/www.sfap.org\/actualite\/table-d-equianalgesie-v8 (acc\u00e8s 2\u00a0mai 2024)."},{"key":"10.1016\/j.revmed.2024.05.010_bib0405","unstructured":"Opioconvert.fr [page d\u2019accueil sur Internet]. Disponible en ligne \u00e0 l\u2019adresse\u00a0: https:\/\/opioconvert.fr (acc\u00e8s 2\u00a0mai 2024)."},{"issue":"12","key":"10.1016\/j.revmed.2024.05.010_bib0410","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1089\/jpm.2021.0309","article-title":"Methadone switching for cancer pain: a new classification of initiation protocols, based on a critical literature review","volume":"24","author":"Treillet","year":"2021","journal-title":"J Palliat Med"},{"key":"10.1016\/j.revmed.2024.05.010_bib0415","unstructured":"Metaconvert [page d\u2019accueil sur Internet]. Disponible en ligne \u00e0 l\u2019adresse\u00a0: https:\/\/www.metaconvert.eu\/fr (acc\u00e8s 2\u00a0mai 2024)."},{"key":"10.1016\/j.revmed.2024.05.010_bib0420","series-title":"DSM-5-TR : manuel diagnostique et statistique des troubles mentaux, texte r\u00e9vis\u00e9","author":"Crocq","year":"2023"},{"issue":"6","key":"10.1016\/j.revmed.2024.05.010_bib0425","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"key":"10.1016\/j.revmed.2024.05.010_bib0215","unstructured":"Respadd.org [page d\u2019accueil sur Internet]. Disponible en ligne \u00e0 l\u2019adresse\u00a0: https:\/\/www.respadd.org\/wp-content\/uploads\/2021\/06\/Livret-opioides-V3-ISBN-sept.20-BAT-1-200908.pdf (acc\u00e8s 2\u00a0mai 2024)."}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324005721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324005721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T23:19:26Z","timestamp":1720653566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866324005721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0248866324005721"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2024.05.010","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bon usage des opio\u00efdes forts dans les unit\u00e9s de m\u00e9decine\u00a0: \u00e9tat des lieux des recommandations et conduite \u00e0 tenir en pratique quotidienne","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2024.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}